Skip to main content

Market Overview

Jefferies & Company Maintains Buy Rating For Core Laboratories (CLB)


Analyst Stephen Gengaro at Jefferies & Company has released an update on Core Laboratories (NYSE: CLB). The company reported its first-quarter results, last week.

Core Laboratories reported first-quarter EPS of $1.38, which was ahead of Jefferies’ estimate of $1.36 and consensus of $1.31.

Jefferies & Company has raised its 2010 revenue and EPS estimates for the company. Revenue estimate has been raised from $774.5 million to $785.8 million, while EPS estimate has been raised from $5.85 to $5.95. The price target for the company has been maintained at $170.

Jefferies & Company has reiterated its Buy rating for Core Laboratories.


Related Articles (CLB)

View Comments and Join the Discussion!

Posted-In: Jefferies & Company Stephen GengaroAnalyst Color Earnings News Markets Analyst Ratings

Latest Ratings

PBTruist SecuritiesMaintains88.0
CFRTruist SecuritiesMaintains111.0
FANGTruist SecuritiesMaintains105.0
SBNYCredit SuisseMaintains250.0
View the Latest Analytics Ratings
Don't Miss Any Updates!
News Directly in Your Inbox
Subscribe to:
Benzinga Premarket Activity
Get pre-market outlook, mid-day update and after-market roundup emails in your inbox.
Market in 5 Minutes
Everything you need to know about the market - quick & easy.
Fintech Focus
A daily collection of all things fintech, interesting developments and market updates.
Everything you need to know about the latest SPAC news.
Thank You

Thank you for subscribing! If you have any questions feel free to call us at 1-877-440-ZING or email us at